The new S3martMed project funded by the COSME programme kicked off in Lyon, France on the 5th and 6th of November 2018. The project’s 5 partner clusters - Lyonbiopole (Auvergne Rhônes-Alpes), BioWin (Wallonia), BioPmed (Piedmont), GAPR-Medsilesia (Upper Silesia) and Bioregion STERN (Baden Wurttemberg) - are all involved in Platform S3 and have decided to set up a new partnership, the European Strategic Cluster Partnership (ESCP) for Smart Specialisation Investments in Medical Technologies, to facilitate interregional and intersectoral collaboration between European clusters and their medtech SME members by setting up a cluster partnership.
The goal of this new project is to identify the skills of each region, but also their financial, business or regulatory needs, to help sustain the sector’s SMEs. S3MARTMED has announced an action plan catering to these SMEs that includes:
• Organizing inter-regional B2B and C2C networks involving SMEs, technology centres and key players in the partners’ regions
• Organizing activities specifically for SMEs in the medtech sector
• Assessing the companies’ readiness and their financial situation, and defining potential investment plans as pilot cases
The aim of the S3MARTMED project, which will span two years, is to “speak with one voice”.
SAFE N MEDTECH, a new European H2020 NMBP (Nanotechnologies, Advanced Materials, Biotechnology and Advanced Manufacturing and Processing) medtech project, has just been launched. BioWin has joined this project as a third party through the Council of European BioRegions (CEBR). This is an opportunity to integrate a future hub of more than 30 medtech partners. BioWin will contribute to the hub’s dissemination and creation.
SAFE-N-MEDTECH will build an innovative open access platform providing reference laboratories and companies with the capabilities, know-how, networks and services needed for developing, testing, evaluating, optimizing and marketing nanotechnology and diagnostic medical devices throughout the products’ entire lifecycle.
This platform will give SMEs, healthcare providers and industries a novel, multi-disciplinary, market-driven approach based on in-depth understanding and knowledge of materials, property, advanced uses and applications in the medtech sector.